A Comparative Evaluation of Regulatory T Cells Profile among Acute and Chronic Cutaneous Leishmaniasis Using Flow Cytometry
- PMID: 31543906
- PMCID: PMC6737365
A Comparative Evaluation of Regulatory T Cells Profile among Acute and Chronic Cutaneous Leishmaniasis Using Flow Cytometry
Abstract
Background: Cutaneous leishmaniasis (CL) is described as a major health problem in many countries of the world. Regulatory T cells (Tregs) are characterized as one of immunologic indexes. One of the best methods to determine of Tregs percentage is flow cytometry. The aim of this study was determination of the role of Tregs profile among acute and chronic forms of human CL using flow cytometry analysis.
Methods: This study was conducted on 24 patients referred to Laboratory of Leishmaniasis, Tehran University of Medical Sciences, Tehran, Iran with acute and 14 patients with chronic phases of CL as well as 15 healthy individuals as control group in 2015-2016. After microscopic examination, 2 ml of peripheral blood samples were collected for determining percentage of CD4 + CD25 + CD127 low Tregs by using flow cytometry method.
Results: Using flow cytometry analysis, the average percentage of Tregs were calculated 5.73, 6.71 and 6.61 for acute, chronic and healthy individuals, respectively. With SPSS software and Scheffe multiple comparison tests, the differences within in these groups are statistically significant (P=0.04) and between the acute and chronic group, there was marginally significant with approximately 91% of confidence level (P=0.088).
Conclusion: Marginally differences were found significantly among averages of Regulatory T cells, acute and chronic phases of CL. Further comprehensive studies can be needed to verify the role of Tregs in both phases of CL cases.
Keywords: Cutaneous leishmaniasis; Flow cytometry; Regulatory T cells.
Conflict of interest statement
Conflict of interest The authors declare that there is no conflict of interests.
Figures
References
-
- Bittencourt AL, Barral A. Evaluation of histopathological classifications of American cutaneous and mucocutaneous leishmaniasis. Mem Inst Oswaldo Cruz. 1991; 86(1):51–6. - PubMed
-
- World Health Organization Control of the leishmaniases, Technical Report Series 949, Report of a meeting of the WHO Expert Committee on the Control of Leishmaniases 2010; Geneva, 22–26 March.
-
- Holakouie-Naieni K, Mostafavi E, Boloorani AD, et al. Spatial modeling of cutaneous leishmaniasis in Iran from 1983 to 2013. Acta Trop. 2017; 166:67–73. - PubMed
-
- Hepburn NC. Cutaneous leishmaniasis: An overview. J Postgrad Med. 2003; 49(1):50–4. - PubMed
-
- Gaafar A, Veress B, Permin H, et al. Characterization of the local and systemic immune responses in patients with cutaneous leishmaniasis due to Leishmania major. Clin Immunol. 1999;91(3):314–20. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials